The cost effectiveness of estrogen use in postmenopausal women was analyzed with use of data from the medical and epidemiologic literature. Risks of endometrial cancer, uterine bleeding, and gallbladder disease were weighed against benefits associated with relief of menopausal symptoms and with prevention of osteoporosis and consequent fractures. Net effects on life expectancy are probably small in either direction, although they are likely to be positive in women with existing osteoporosis or prior hysterectomy. Treatment appears to be relatively cost effective in menopausal women with prior hysterectomy or osteoporosis but does not appear to be cost effective as a prophylactiv measure in asymptomatic women with intact uteri. For women with menopausal symptoms and intact uteri, the decision to prescribe estrogens for the individual patient and the cost effectiveness of estrogen use at the societal level depend critically on the subjective values assigned to symptomatic relief.
This article has been cited by other articles:
Krieger, N., Lowy, I., Aronowitz, R., Bigby, J., Dickersin, K., Garner, E., Gaudilliere, J.-P., Hinestrosa, C., Hubbard, R., Johnson, P. A, Missmer, S. A, Norsigian, J., Pearson, C., Rosenberg, C. E, Rosenberg, L., Rosenkrantz, B. G, Seaman, B., Sonnenschein, C., Soto, A. M, Thornton, J., Weisz, G.
(2005). Hormone replacement therapy, cancer, controversies, and women's health: historical, epidemiological, biological, clinical, and advocacy perspectives. J. Epidemiol. Community Health
59: 740-748
[Abstract][Full Text]
Minelli, C., Abrams, K. R, Sutton, A. J, Cooper, N. J
(2004). Benefits and harms associated with hormone replacement therapy: clinical decision analysis. BMJ
328: 371-
[Abstract][Full Text]
Gosden, T. B, Torgerson, D. J
(2002). Economics notes: Converting international cost effectiveness data to UK prices. BMJ
325: 275-276
[Full Text]
Iglesias, C.P., Torgerson, D.J., Bearne, A., Bose, U.
(2002). The cost utility of bisphosphonate treatment in established osteoporosis. QJM
95: 305-311
[Abstract][Full Text]
Torgerson, D. J., Thomas, R. E., Campbell, M. K., Reid, D. M.
(1997). Randomized Trial of Osteoporosis Screening: Use of Hormone Replacement Therapy and Quality-of-Life Results. Arch Intern Med
157: 2121-2125
[Abstract]
Belchetz, P. E.
(1994). Hormonal Treatment of Postmenopausal Women. NEJM
330: 1062-1071
[Full Text]
Udvarhelyi, I. S., Colditz, G. A., Rai, A., Epstein, A. M.
(1992). Cost-Effectiveness and Cost-Benefit Analyses in the Medical Literature: Are the Methods Being Used Correctly?. ANN INTERN MED
116: 238-244
[Abstract]
Tosteson, A. N. A., Rosenthal, D. I., Melton, L. J. III, Weinstein, M. C.
(1990). Cost Effectiveness of Screening Perimenopausal White Women for Osteoporosis: Bone Densitometry and Hormone Replacement Therapy. ANN INTERN MED
113: 594-603
[Abstract]
La Puma, J., Lawlor, E. F.
(1990). Quality-Adjusted Life-Years: Ethical Implications for Physicians and Policymakers. JAMA
263: 2917-2921
[Abstract]
Melton, L. J. III, Eddy, D. M., Johnston, C. C. Jr.
(1990). Screening for Osteoporosis. ANN INTERN MED
112: 516-528
[Abstract]
KASSIRER, J. P., MOSKOWITZ, A. J., LAU, J., PAUKER, S. G.
(1987). Decision Analysis: A Progress Report. ANN INTERN MED
106: 275-291
[Abstract]
CUMMINGS, S. R., BLACK, D.
(1986). Should Perimenopausal Women Be Screened for Osteoporosis?. ANN INTERN MED
104: 817-823
[Abstract]
Detsky, A. S., Mclaughlin, J. R., Abrams, H. B., Whittaker, J. S., Whitwell, J., L'Abbe, K., Jeejeebhoy, K. N.
(1986). A Cost-Utility Analysis of the Home Parenteral Nutrition Program at Toronto General Hospital: 1970-1982. JPEN J Parenter Enteral Nutr
10: 49-57
[Abstract]
Anderson, J. P., Moser, R. J.
(1985). Parasite Screening and Treatment Among Indochinese Refugees: Cost-Benefit/Utility and the General Health Policy Model. JAMA
253: 2229-2235
[Abstract]
Evans, R. W.
(1983). Health Care Technology and the Inevitability of Resource Allocation and Rationing Decisions: Part II. JAMA
249: 2208-2219
[Abstract]
Council on Scientific Affairs,
(1983). Estrogen Replacement in the Menopause. JAMA
249: 359-361
[Abstract]
ENDOCRINOLOGY AND METABOLISM COMMITTEE, , MEDICAL KNOWLEDGE SELF-ASSESSMENT PROGRAM VI, , AMERICAN COLLEGE OF PHYSICIANS,
(1982). Endocrinology and Metabolism: An Annotated Bibliography of Recent Literature: References to Journal Articles and Other Papers. ANN INTERN MED
97: 151-157
[Abstract]
Korenman, S. G.
(1982). Menopausal Endocrinology and Management. Arch Intern Med
142: 1131-1136
[Abstract]
Weinstein, M. C.
(1981). Economic Assessments of Medical Practices and Technologies. Med Decis Making
1: 309-330
Previous
